Julie Bertrand

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

CPT: pharmacometrics & systems pharmacology

Antimicrobial agents and chemotherapy

The AAPS journal

British journal of clinical pharmacology

INSERM

Université Paris Diderot (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Jan 01 2016

France

Charge de Recherche 2eme classe :: IAME UMR1337 BIPID

Education History

Université Paris Diderot Oct 01 2006 - Dec 04 2009

France

PHD

Publications

Mélanie Guhl, Julie Bertrand, Lucie Fayette, Francois Mercier, Emmanuelle Comets
Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. The AAPS journal 26 (4) (2024)
Gaelle Baudemont, Coralie Tardivon, Guillaume Monneret, Martin Cour, Thomas Rimmelé, Lorna Garnier, Hodane Yonis, Jean-Christophe Richard, Remy Coudereau, Morgane Gossez, Florent Wallet, Marie-Charlotte Delignette, Frederic Dailler, Marielle Buisson, Anne-Claire Lukaszewicz, Laurent Argaud, Cédric Laouénan, Julie Bertrand, Fabienne Venet, null null
Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients. CPT: pharmacometrics & systems pharmacology 13 (7) (2024)
Mélanie Guhl, Julie Bertrand, Lucie Fayette, Francois Mercier, Emmanuelle Comets
Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. The AAPS journal 26 (3) (2024)
Gaelle Baudemont, Coralie Tardivon, Guillaume Monneret, Martin Cour, Thomas Rimmelé, Lorna Garnier, Hodane Yonis, Jean-Christophe Richard, Remy Coudereau, Morgane Gossez, Florent Wallet, Marie-Charlotte Delignette, Frederic Dailler, Marielle Buisson, Anne-Claire Lukaszewicz, Laurent Argaud, Cédric Laouénan, Julie Bertrand, Fabienne Venet, null null
Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients. CPT: pharmacometrics & systems pharmacology 13 (7) (2024)
Mélanie Guhl, Julie Bertrand, Lucie Fayette, Francois Mercier, Emmanuelle Comets
Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. The AAPS journal 26 (3) (2024)
Mélanie Guhl, Julie Bertrand, Lucie Fayette, Francois Mercier, Emmanuelle Comets
Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. The AAPS journal 26 (4) (2024)
Gaelle Baudemont, Coralie Tardivon, Guillaume Monneret, Martin Cour, Thomas Rimmelé, Lorna Garnier, Hodane Yonis, Jean-Christophe Richard, Remy Coudereau, Morgane Gossez, Florent Wallet, Marie-Charlotte Delignette, Frederic Dailler, Marielle Buisson, Anne-Claire Lukaszewicz, Laurent Argaud, Cédric Laouénan, Julie Bertrand, Fabienne Venet, null null
Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients. CPT: pharmacometrics & systems pharmacology (2024)
Gaelle Baudemont, Coralie Tardivon, Guillaume Monneret, Martin Cour, Thomas Rimmelé, Lorna Garnier, Hodane Yonis, Jean-Christophe Richard, Remy Coudereau, Morgane Gossez, Florent Wallet, Marie-Charlotte Delignette, Frederic Dailler, Marielle Buisson, Anne-Claire Lukaszewicz, Laurent Argaud, Cédric Laouénan, Julie Bertrand, Fabienne Venet, null null
Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients. CPT: pharmacometrics & systems pharmacology 13 (7) (2024)
Mélanie Guhl, Julie Bertrand, Lucie Fayette, Francois Mercier, Emmanuelle Comets
Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. The AAPS journal 26 (3) (2024)
Coralie Tardivon, Florence Loingeville, Mark Donnelly, Kairui Feng, Wanjie Sun, Guoying Sun, Stella Grosser, Liang Zhao, Lanyan Fang, France Mentré, Julie Bertrand
Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studies. CPT: pharmacometrics & systems pharmacology (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Matthew Roughley, Carlos Mena, Robert Howard, Suzanne J Reeves, Julie Bertrand
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring. British journal of clinical pharmacology (2023)
Marion Kerioui, Julie Bertrand, Solène Desmée, Christophe Le Tourneau, Francois Mercier, René Bruno, Jeremie Guedj
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter? JCO precision oncology 7 (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy (2023)
Marion Kerioui, Julie Bertrand, Solène Desmée, Christophe Le Tourneau, Francois Mercier, René Bruno, Jeremie Guedj
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter? JCO precision oncology 7 (2023)
Matthew Roughley, Carlos Mena, Robert Howard, Suzanne J Reeves, Julie Bertrand
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring. British journal of clinical pharmacology (2023)
Marion Kerioui, Julie Bertrand, René Bruno, François Mercier, Jérémie Guedj, Solène Desmée
Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models. British journal of clinical pharmacology 88 (4) (2022)
Camille Couffignal, France Mentré, Julie Bertrand
Impact of study design and statistical model in pharmacogenetic studies with gene-treatment interaction. CPT: pharmacometrics & systems pharmacology 10 (4) (2021)
Julie Bertrand
Bioequivalence and Statistics in Clinical Pharmacology. Journal of biopharmaceutical statistics (2017)
Philippine Eloy, Adrien Tessier, Patty Fan-Havard, Monidarin Chou, Céline Verstuyft, Anne-Marie Taburet, David W Haas, Julie Bertrand, null null
Genetics of Nevirapine Metabolic Pathways at Steady State in HIV-Infected Cambodians. Antimicrobial agents and chemotherapy 61 (12) (2017)

Julie Bertrand.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Julie Bertrand